A study evaluating effect of immunization campaign using the 4-component protein-based meningococcal vaccine (MenB-4C) in Saguenay-Lac-Saint-Jean (SLSJ) region.

Trial Profile

A study evaluating effect of immunization campaign using the 4-component protein-based meningococcal vaccine (MenB-4C) in Saguenay-Lac-Saint-Jean (SLSJ) region.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Meningococcal vaccine group B (Primary)
  • Indications Meningococcal group B infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top